Vasc Spec Int.  2019 Jun;35(2):77-89. 10.5758/vsi.2019.35.2.77.

State-of-the-Art Strategies for the Vascularization of Three-Dimensional Engineered Organs

Affiliations
  • 1Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA. surgeonmsi@gmail.com, jyoo@wakehealth.edu
  • 2Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.

Abstract

Engineering three-dimensional (3D) implantable tissue constructs is a promising strategy for replacing damaged or diseased tissues and organs with functional replacements. However, the efficient vascularization of new 3D organs is a major scientific and technical challenge since large tissue constructs or organs require a constant blood supply to survive in vivo. Current approaches to solving this problem generally fall into the following three major categories: (a) cell-based, (b) angiogenic factor-based, and (c) scaffold-based. In this review, we summarize state-of-the-art technologies that are used to develop complex, stable, and functional vasculature for engineered 3D tissue constructs and organs; additionally, we have suggested directions for future research.

Keyword

Bioengineering; Angiogenesis; Tissue scaffolds

MeSH Terms

Bioengineering
Tissue Scaffolds
Full Text Links
  • VSI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr